Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.45 |
| ▸ | MEN1 | O00255 | 4/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13812937 | 0.93 | TAS1R3 (0.42) | KMT2AMEN1CA12CA1CA2 | |
| SCHEMBL10092169 | 0.89 | KMT2A (0.42) | KMT2AMEN1CA12CA1CA2 | |
| SCHEMBL7624317 | 0.85 | ALDH1A1 (0.48) | KMT2AMEN1CA12CA1CA2 | |
| SCHEMBL10092062 | 0.82 | CA12 (0.47) | KMT2ACA12CA1CA2CA7 | |
| SCHEMBL3243587 | 0.82 | CA12 (0.53) | KMT2AMEN1CA12CA1CA2 | |
| SCHEMBL7187688 | 0.78 | CA12 (0.46) | KMT2AMEN1CA12CA1CA2 | |
| SCHEMBL7187925 | 0.77 | CA12 (0.45) | KMT2AMEN1CA12CA1CA2 | |
| SCHEMBL13588667 | 0.77 | CA12 (0.47) | KMT2AMEN1CA12CA1CA2 | |
| SCHEMBL7184586 | 0.76 | ALDH1A1 (0.49) | KMT2AMEN1CA12CA1CA2 | |
| SCHEMBL7180806 | 0.76 | CA12 (0.50) | KMT2AMEN1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120019938-A1 | CURABLE RESIN COMPOSITION FOR CEMENTED LENS, IMAGING LENS, AND METHOD FOR MANUFACTURING IMAGING LENS | FUJIFILM CORPORATION (JP) | 2012-01-26 | — | — | US | disclosed |
| US-20120019938-A1 | CURABLE RESIN COMPOSITION FOR CEMENTED LENS, IMAGING LENS, AND METHOD FOR MANUFACTURING IMAGING LENS | FUJIFILM CORPORATION (JP) | 2012-01-26 | — | — | US | disclosed |
| US-20090297955-A1 | OPTICAL RECORDING COMPOSITION, HOLOGRAPHIC RECORDING MEDIUM, AND METHOD OF RECORDING AND REPRODUCING INFORMATION | FUJIFILM CORPORATION (JP) | 2009-12-03 | — | — | US | disclosed |
| US-20090297955-A1 | OPTICAL RECORDING COMPOSITION, HOLOGRAPHIC RECORDING MEDIUM, AND METHOD OF RECORDING AND REPRODUCING INFORMATION | FUJIFILM CORPORATION (JP) | 2009-12-03 | — | — | US | disclosed |
| US-20090202920-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-08-13 | — | — | US | disclosed |
| US-20090202920-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-08-13 | — | — | US | disclosed |
| US-20090202921-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-08-13 | — | — | US | disclosed |
| US-20090202921-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-08-13 | — | — | US | disclosed |
| US-20090170009-A1 | HOLOGRAPHIC RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-07-02 | — | — | US | disclosed |
| US-20090170009-A1 | HOLOGRAPHIC RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-07-02 | — | — | US | disclosed |
| US-20090170008-A1 | HOLOGRAPHIC RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-07-02 | — | — | US | disclosed |
| US-20090170008-A1 | HOLOGRAPHIC RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-07-02 | — | — | US | disclosed |
| US-20090142672-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-06-04 | — | — | US | disclosed |
| US-20090142672-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-06-04 | — | — | US | disclosed |
| US-20090142671-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-06-04 | — | — | US | disclosed |
| US-20090142671-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090202921-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | CHRNA6, NR2E3, NR4A1 | KMT2A 2284/4885MEN1 2739/4885CA12 499/4885 |
| US-20090170009-A1 | HOLOGRAPHIC RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | KAT2B, H1-0, RPLP2 | KMT2A 1633/4885MEN1 3341/4885CA12 273/4885 |
| US-20090202920-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | CHAT, HCN2, HCN1 | KMT2A 1143/4885MEN1 2397/4885CA12 47/4885 |
| US-20090142671-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | CACNA1S, CACNA1E, CRY1 | KMT2A 1072/4885MEN1 1298/4885CA12 337/4885 |
| US-20090142672-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | CRY1, CRY2, CACNA1B | KMT2A 1407/4885MEN1 2658/4885CA12 345/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.